Skip to main content
BOTANIX PHARMACEUTICALS LTD logo

BOTANIX PHARMACEUTICALS LTD — Investor Relations & Filings

Ticker · BOT ISIN · AU000000BOT2 ASX Manufacturing
Open in API
Filings indexed 1,209 across all filing types
Latest filing 2023-07-06 Capital/Financing Update
Country AU Australia
Listing ASX BOT

About BOTANIX PHARMACEUTICALS LTD

https://botanixpharma.com/

Botanix Pharmaceuticals Ltd is a clinical-stage pharmaceutical company focused on the development and commercialization of novel topical treatments for serious skin conditions. The company utilizes its proprietary Permetrex™ skin delivery technology, which is designed to improve the delivery of active ingredients through the skin. Its primary product, Sofdra™ (sofpironium bromide), is an FDA-approved prescription topical gel for the treatment of primary axillary hyperhidrosis. The company's research and development pipeline also includes clinical-stage candidates for the treatment of acne, rosacea, and atopic dermatitis. Botanix aims to address significant unmet medical needs in dermatology by providing innovative therapeutic solutions with enhanced safety and efficacy profiles.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BOT 6 pages 27.9KB
Capital/Financing Update Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance of new fully paid ordinary shares resulting from the exercise of options or conversion of convertible securities. It includes specifics such as the number of securities, issue date, issue price, and the status of quoted and unquoted securities. This is a formal announcement related to changes in the company's capital structure, specifically the issuance and quotation of new shares. It is not a financial report, earnings release, or management discussion, but rather a capital/financing update regarding securities issuance and quotation. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a mere announcement of a report but a substantive filing about securities issuance.
2023-07-06 English
Section 708A(5)(e) Notice 2 pages 157.3KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of new shares by Botanix Pharmaceuticals Limited. It provides legal and regulatory information about the share issue and compliance with disclosure requirements. The document is short (3502 characters) and serves as a formal announcement of a share issue event rather than a detailed financial report or analysis. It does not contain financial statements or substantive financial data. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2023-07-06 English
Application for quotation of securities - BOT 6 pages 27.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. This is a formal announcement related to the company's capital structure changes, specifically the issuance and quotation of new shares resulting from option exercises. It does not contain financial statements, management discussion, or audit information. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive filing about capital changes.
2023-06-26 English
Section 708A(5)(e) Notice 2 pages 157.5KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issue of new shares by Botanix Pharmaceuticals Limited. It provides legal and regulatory information about the share issuance and compliance with disclosure requirements. The document is short (3499 characters) and serves as a formal announcement of a capital raising event through the exercise of options, rather than a detailed financial report or a full capital/financing update report. It does not contain financial statements or substantive financial data but is a regulatory notice about the share issue. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-06-26 English
Application for quotation of securities - BOT 6 pages 27.9KB
Capital/Financing Update Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. This is a formal announcement related to changes in the company's capital structure, specifically the issuance of new shares due to option exercises. It is not a financial report, earnings release, or management discussion, but rather a capital/financing update regarding securities quotation. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive update on capital changes.
2023-06-14 English
Section 708A(5)(e) Notice 2 pages 157.8KB
Regulatory Filings Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issue of new shares by Botanix Pharmaceuticals Limited. It provides legal and regulatory information about the share issuance and compliance with disclosure requirements. The document is short (3499 characters) and serves as a formal notification rather than a detailed financial report or analysis. It does not contain financial statements, management discussion, or detailed investor presentation content. Therefore, it fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into more specific categories like capital changes or earnings releases.
2023-06-14 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.